|
Glenmark Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
52376.47 Cr.
|
P/BV
|
6.20
|
Book Value (Rs.)
|
299.28
|
|
52 Week High/Low (Rs.)
|
1843/1272
|
FV/ML
|
1/1
|
P/E(X)
|
50.02
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
37.10
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 9925.70 | 8750.15 | 9616.40 | 9213.05 | 8084.03 |
| Other Operating Income | 139.83 | 0.00 | 0.00 | 72.71 | 0.00 |
| Total Income From Operations | 10065.53 | 8750.15 | 9616.40 | 9285.76 | 8084.03 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2206.50 | 2403.51 | 2717.00 | 2488.82 | 2351.93 |
| Purchase of Traded Goods | 1221.26 | 1240.36 | 1037.87 | 879.26 | 572.70 |
| Increase/Decrease in Stocks | -163.36 | -226.04 | -410.02 | -13.67 | -164.18 |
| Employees Cost | 2285.49 | 2167.19 | 2123.38 | 1869.74 | 1806.50 |
| Depreciation | 360.81 | 430.57 | 464.74 | 355.19 | 332.49 |
| Other Expenses | 2725.29 | 2474.13 | 2474.77 | 2204.70 | 1956.13 |
| Total Expenses | 8635.99 | 8489.73 | 8407.73 | 7784.05 | 6855.56 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1429.55 | 260.42 | 1208.67 | 1501.71 | 1228.47 |
| Other Income | 102.04 | 66.83 | 357.00 | 59.47 | 41.72 |
| P/L Before Interest, Excpt. Items & Tax | 1531.59 | 327.25 | 1565.67 | 1561.18 | 1270.19 |
| Interest | 140.35 | 367.41 | 240.33 | 211.24 | 269.78 |
| P/L Before Exceptional Items & Tax | 1391.23 | -40.16 | 1325.34 | 1349.94 | 1000.41 |
| Exceptional Items | 0.00 | -454.17 | 33.88 | -178.38 | 44.55 |
| P/L Before Tax | 1391.23 | -494.33 | 1359.22 | 1171.56 | 1044.96 |
| Tax | 348.48 | 97.87 | 578.68 | 350.47 | 308.74 |
| P/L After Tax from Ordinary Activities | 1042.75 | -592.20 | 780.54 | 821.08 | 736.21 |
| Extra Ordinary Item | 0.00 | 372.95 | 0.00 | 0.00 | 0.00 |
| Net Profit/Loss For the Period | 1042.75 | -219.25 | 780.54 | 821.08 | 736.21 |
| Net P/L After Minority Interest & Share Of Associates | 1042.75 | -219.25 | 780.54 | 821.08 | 736.21 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 36.95 | -10.04 | 25.71 | 27.86 | 26.09 |
| Diluted EPS (Rs.) | 36.95 | -10.04 | 25.71 | 27.86 | 26.09 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 36.95 | -10.04 | 25.71 | 27.86 | 26.09 |
| Diluted EPS (Rs.) | 36.95 | -10.04 | 25.71 | 27.86 | 26.09 |
| | | | | | |
| PBITOE Margin (%) | 14.20 | 2.97 | 12.56 | 16.17 | 15.19 |
| PBTE Margin (%) | 13.82 | -0.45 | 13.78 | 14.53 | 12.37 |
| PBT Margin (%) | 13.82 | -5.64 | 14.13 | 12.61 | 12.92 |
| PAT Margin (%) | 10.35 | -2.50 | 8.11 | 8.84 | 9.10 |
| PAT After MI And SOA Margin (%) | 10.35 | -2.50 | 8.11 | 8.84 | 9.10 |
